Patients with blood cancer can be spared chemotherapy with two daily tablets

Two tablets a day could soon save some blood cancer patients from grueling periods of chemotherapy. The drug, called ruxolitinib, can keep a type of blood cancer called polycythemia vera in remission for up to three years longer than traditional methods, according to British research. About one-third of patients with […]